Article
The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer
10 Aug 2016
Abstract excerpt
Metformin, a drug approved for diabetes type II treatment, has been associated with a reduction in the incidence of breast cancer and metastasis and increased survival in diabetic breast cancer patients. High levels of miR-26a expression have been proposed as one of the possible mechanisms for this effect; likewise, this miRNA has also been associated with survival/apoptosis processes in breast cancer. Our aim...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
